Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -7.7% | +40.1% | 1 / 3 | -5.4% | -4.12 pp | -0.70 pp | +22.0% | 0.70 | 3.42 | 123 | −5,4% | 34,3 | −7,7% | 3.42 | 7.65 | −55,3% |
| Pts | 0 | 8 | 4 | 0 | 0 | 4 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 18.850 (close price on 2026-10-19)EPS (TTM): 5.514
Financial charts
1.Revenue & growth
VND bn123Q2/26
1.Revenue & growth
VND bn123Q2/26
2.Profit & growth
VND bn34,3Q2/26
3.Profit mix (Penman)
VND bn154Q2/26
4.Margins & cost structure
%42.2%Q2/26
5.Returns & cash cycle
% · days22.3%Q2/26
6.Earnings quality & cash
VND bn240Q2/26
7.Asset structure
VND bn1.605Q2/26
8.Funding & debt health
VND bn · times1.605Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %3,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.374Q2/26
Adjusted EPS growth, latest quarter
-7.7%
Average adjusted EPS growth, 3 quarters
40.1%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26